Synthetic Studies of Reveromycin A : An Inhibitor of Eukaryotic Cell Growth
| Project/Area Number |
12672082
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Chemical pharmacy
|
|---|
| Research Institution | RIKEN (The Institute of Physical and Chemical Reseach) |
|---|
Principal Investigator |
SHIMIZU Takeshi RIKEN(The Institute of Physical and Chemical Reseach), Synthetic Organic Chemistry Laboratory, Senior Scientist, 有機合成化学研究室, 副主任研究員 (80087569)
|
|---|
| Project Period (FY) |
2000 – 2001
|
| Project Status |
Completed (Fiscal Year 2001)
|
| Budget Amount *help |
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2000: ¥2,500,000 (Direct Cost: ¥2,500,000)
|
|---|
| Keywords | reveromycin A / inhibitor of eukaryotic cell growth / inhibitor of protein synthesis / anti-tumor agent / 6, 6-spiroacetal / asymmetric total synthesis / succinylation / reaction under high pressure / 6,6-スピロケタール / Julia olefination |
|---|
| Research Abstract |
Reveromybin A is a novel polyketide-type antibiotic produced by Steptomyces sp. and inhibits mitogenic activity induced by the epidennal growth factor in a mouse epidermal keratinocyte. The characteristic structural features of reveromycin A include a 1, 7-dioxaspiro[5.5]undecane moiety, that is, the 6, 6-splroacetal system bearing a hemisuccinate, two alkenyl carboxylic acids, and methyl and n.-butyl groups. The first total synthesis of reveromycin A has been designed and accomplished. Our synthesis is based on the stereoselective and convergent synthesis of the 6, 6-spiroacetal system followed by the succinylation of tertiary alcohol under high pressure and the installation of the polyene-containing side chains. We also studied the syntheses and activities of reveromycin A derivatives.
|
Report
(3 results)
Research Products
(6 results)
